期刊文献+
共找到3篇文章
< 1 >
每页显示 20 50 100
黄芪对气虚证2型糖尿病患者的临床疗效
1
作者 杨芸艺 杨宏杰 +5 位作者 张立娟 陈琳 侯可可 尹宏萍 雷涛 沙雯君 《中成药》 CAS CSCD 北大核心 2024年第10期3278-3283,共6页
目的探讨黄芪对气虚证2型糖尿病患者的临床疗效。方法90例患者随机分为对照组和观察组,每组45例,2组均采用常规治疗,同时对照组给予原治疗方案,观察组在对照组基础上加用黄芪颗粒,疗程12周。检测中医证候疗效和评分、血管内皮功能指标... 目的探讨黄芪对气虚证2型糖尿病患者的临床疗效。方法90例患者随机分为对照组和观察组,每组45例,2组均采用常规治疗,同时对照组给予原治疗方案,观察组在对照组基础上加用黄芪颗粒,疗程12周。检测中医证候疗效和评分、血管内皮功能指标及炎症因子(FMD、NO、ET-1、MHR、CRP)、糖代谢指标(FBG、2 hPBG、HbA1C、FCP)、脂代谢指标(TC、TG、HDL-C、LDL-C)、安全性指标变化。结果观察组中医证候总有效率高于对照组(P<0.05)。治疗后,观察组FMD、NO高于对照组(P<0.05),MHR、2 hPBG、HbA1C、TC、TG及气短、神疲、乏力评分更低(P<0.05)。2组未发现明显不良反应。结论黄芪可安全有效地改善气虚证2型糖尿病患者血管内皮功能障碍,值得临床推广。 展开更多
关键词 黄芪 2型糖尿病 气虚
下载PDF
虎杖对湿热证2型糖尿病患者的临床疗效
2
作者 徐媛颖 孔稳稳 +5 位作者 尹宏萍 张会会 蔡兴华 徐碧林 沙雯君 雷涛 《中成药》 CAS CSCD 北大核心 2024年第8期2596-2600,共5页
目的探讨虎杖对湿热证2型糖尿病患者的临床疗效。方法140例患者随机分为对照组和观察组,每组70例,对照组给予常规治疗,观察组在对照组基础上加用虎杖颗粒,疗程8周。检测体质量、BMI、血糖指标(FBG、2 h PG、HbA_(1C)、GA)、血脂指标(TC... 目的探讨虎杖对湿热证2型糖尿病患者的临床疗效。方法140例患者随机分为对照组和观察组,每组70例,对照组给予常规治疗,观察组在对照组基础上加用虎杖颗粒,疗程8周。检测体质量、BMI、血糖指标(FBG、2 h PG、HbA_(1C)、GA)、血脂指标(TC、TG、HDL-C、LDL-C、ApoA-I、ApoB、ApoA、ApoE、sdLDL-C)、肝功能指标(ALT、AST)、脂肪肝程度、TyG、HSI、中医证候评分和疗效变化。结果观察组中医证候总有效率高于对照组(P<0.01),脂肪肝程度更轻(P<0.01)。治疗后,观察组体质量、BMI、FBG、GA、TG、ApoE、TyG、HSI、ALT、中医证候评分降低(P<0.05,P<0.01),并且2 h PG、TyG、HSI、ALT、中医证候评分低于对照组(P<0.05,P<0.01)。结论虎杖可改善湿热证2型糖尿病患者糖脂代谢紊乱,值得临床推广应用。 展开更多
关键词 虎杖 常规治疗 2型糖尿病 湿热证
下载PDF
Berberine Induces Cell Apoptosis through Cytochrome C/Apoptotic Protease-Activating Factor 1/Caspase-3 and Apoptosis Inducing Factor Pathway in Mouse Insulinoma Cells 被引量:4
3
作者 FANG Xin MIAO Xiao-liang +8 位作者 LIU Jun-li ZHANG Dong-wei WANG Min ZHAO Dan-dan MU Qian-qian YU Na MO Fang-fang yin hong-ping GAO Si-hua 《Chinese Journal of Integrative Medicine》 SCIE CAS CSCD 2019年第11期853-860,共8页
Objective:To investigate apoptotic effects of berberine,a significant alkaloids component existing in Rhizoma coptidis,and its possible acting mechanism in insulinoma cells.Methods:Different concentrations of berberin... Objective:To investigate apoptotic effects of berberine,a significant alkaloids component existing in Rhizoma coptidis,and its possible acting mechanism in insulinoma cells.Methods:Different concentrations of berberine were used to treat mouse insulinoma(MIN6)cells for various period of time.The viability and apoptosis of the cells were analyzed using methylthiazolyldiphenvl-tetrazolium bromide assay,flow cytometry and enzyme-linked immuno sorbent assay.Changes in the relating pro-and anti-apoptosis proteins were detected by western-blotting.Results:The half-maximal inhibitory concentration(IC50)of berberine was 5.7μmol/L on MIN6 cells viability for 16 h.Berberine caused a 20%reduction(P<0.05)in cell number after only 4-h incubation;which reached 50%after 24 h(P<0.01).Berberine treatment for 16 h significantly increased the level of DNA fragmentation.The flow cytometry showed the apoptotic rate increased 2.9-and 4.6-fold after treating with berberine(5μmol/L)for 8 and 16 h,while 3-and 8.7-fold after 10μmol/L treatment for 8 and 16 h(P<0.01).Berberine treatment dramatically elevated the expression ratio of Bax to Bcl-2.Meanwhile,berberine notably increased the apoptosis-inducing factors and cytochrome C transforming from the mitochondria to the cytoplasm.Apoptotic protease-activating factor 1(Apaf-1)was subsequently activated after cytochrome C release.Furthermore,caspase-3 and poly adenosine diphosphate-ribose polymerase were also activated to trigger apoptosis cascade.Conclusion:High concentration(5 and 10μmol/L)of berberine could induce the apoptosis of MIN6 cells through cytochrome C/Apaf-1/caspase-3 and apoptosis inducing factor(AIF)pathway. 展开更多
关键词 Chinese medicine BERBERINE APOPTOSIS MOUSE INSULINOMA cells cytochrome C/Apaf-1/caspase-3 APOPTOSIS inducing factor PATHWAY
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部